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Summary
Background: Sorting ubiquitinated epidermal growth factor
receptor (EGFR) to the intralumenal vesicles of the multive-
sicular body requires the coordinated action of several ESCRT
complexes. A central question is how EGFR transits vectorially
from early, ubiquitin-binding ESCRTs to the final complex,
ESCRT-III, such that cargo sequestration is coupled with intra-
lumenal vesicle formation.
Results:We show that the ESCRT accessory protein HD-PTP/
PTPN23 associates with EGFR and combines with the deubi-
quitinating enzyme UBPY/USP8 to transfer EGFR from
ESCRT-0 to ESCRT-III and drive EGFR sorting to intralumenal
vesicles. HD-PTP binds ESCRT-0 via two interactions with the
STAM2 subunit. First, the HD-PTP Bro1 domain binds the core
domain of STAM2. This is competed by the ESCRT-III subunit
CHMP4B, which binds an overlapping site on HD-PTP Bro1.
Second, a proline-rich peptide in HD-PTP binds the SH3
domain of STAM2. Similar proline-rich peptides on UBPY
also bind STAM2 SH3 to facilitate EGFR deubiquitination.
Hence, locally recruited UBPY would be expected to compete
with HD-PTP for STAM2binding at this second site. Indeed, we
show that HD-PTP recruits UBPY to EGFR. Association of
UBPY with HD-PTP involves UBPY interacting with HD-PTP-
bound CHMP4B, as well as additional interaction(s) between
UBPY and HD-PTP.
Conclusions: This study identifies HD-PTP as a central coor-
dinator of the ESCRT pathway for EGFR. Based on these
studies, we propose a model whereby the concerted recruit-
ment of CHMP4B and UBPY to HD-PTP and the engagement
of UBPY by STAM2 displaces ESCRT-0 from HD-PTP, deubi-
quitinates EGFR, and releases ESCRT-0 from cargo in favor
of ESCRT-III.Introduction
Activation of EGFR (ErbB1) is followed by its clathrin-depen-
dent endocytosis [1]. Although some EGFR is recycled, a
significant portion is ubiquitinated and sorted to intralumenal
vesicles (ILVs) within the multivesicular body (MVB) [2], then
trafficked to the lysosome. MVB sorting is mediated by the
endosomal sorting complex required for sorting (ESCRT) path-
way, several protein complexes (ESCRTs 0–III) that collectively
drive MVB cargo selection and ILV formation [3–5].
ESCRTs 0–II contain ubiquitin-binding proteins, each of
which may help sequester ubiquitinated EGFR. For example,3These authors contributed equally to this work
*Correspondence: philip.woodman@manchester.ac.ukESCRT-0 is a heterodimer of hepatocyte growth factor regu-
lated substrate (Hrs) and signal transducing adapter molecule
(STAM1/2) [6]. Hrs binds ubiquitin via a double-sided ubiquitin
interactingmotif (DUIM) and a Vps27, Hrs, STAM (VHS) domain
[7, 8], whereas STAM contains UIM and VHS domains [8, 9].
ESCRT-I [3] contains the ubiquitin E2 variant (UEV) domain
of tumor susceptibility gene 101 (TSG101) [10] and overlapping
ubiquitin associated (UBA) domains within ubiquitin associ-
ated protein 1 (UBAP1) [11, 12]. Finally, ESCRT-II pos-
sesses a GRAM-like ubiquitin-binding motif in EAP45 (GLUE)
domain [13].
ESCRT-III appears not to bind ubiquitin directly. This
complex, best defined in yeast, assembles on endosomes
from cytosolic subunits. First, ESCRT-II recruits and activates
one subunit, Vps20p (mammalian chargedmultivesicular body
protein 6 [CHMP6]) [14]. Vps20p seeds assembly of an Snf7p
(CHMP4) polymer, which is capped by Vps24p (CHMP3) and
Vps2p (CHMP2) [15]. The ESCRT-III polymer is pivotal for
membrane deformation and cargo capture into ILVs [4, 15].
Several deubiquitinating enzymes (DUBs) regulate MVB
sorting [16]. In particular, two DUBs, associated molecule
with the SH3 domain of STAM (AMSH) and ubiquitin specific
peptidase 8 (USP8/UBPY), bind to the SH3 domain of STAM
and also interact via their microtubule interacting and trans-
port (MIT) domains with multiple ESCRT-III subunits [17–22].
The significance of these DUBs binding both early and late
ESCRTs remains unexplained. Indeed, the roles of AMSH
and UBPY are controversial. Several studies identify UBPY
as promoting EGFR degradation [23–27], but others argue
that it ‘‘proofreads’’ ubiquitinated EGFR, allowing the receptor
to escape the ESCRT pathway and be recycled [28, 29]. Like-
wise, ‘‘degradative’’ and proofreading functions have both
been ascribed to AMSH [25, 30, 31]. Here we demonstrate
that UBPY collaborateswith His domain protein tyrosine phos-
phatase/protein tyrosine phosphatase type N23 (HD-PTP/
PTPN23), a regulator of ESCRT-dependent EGFR trafficking
[32], to drive EGFR sorting to the MVB.
Results
HD-PTP Is Dispensable for ILV Formation but Essential
for Efficient EGFR Sorting
HD-PTP is important for the endosomal transit of EGFR [32].
To detail where HD-PTP acts, we examined EGFR trafficking
by EM. Gold-labeled anti-EGFR was bound to cells, which
were then pulsed with EGF for w30 min and subjected to
high-pressure freezing to preserve morphology. In control
cells, early endosomes (EE) and maturing MVBs contained
ILVs labeled with anti-EGFR-gold (Figures 1A and 1B; Table 1).
Tomograms revealed associated vesicles, buds and tubules,
inward buds, and ILVs (Figure S1A and Movie S1 available
online). In contrast, HD-PTP-depleted cells had few isolated
EEs/MVBs, and anti-EGFR-gold mainly localized to peripheral
tubulovesicular elements and to membrane clusters with
complex morphologies and some electron-dense content
(Figures 1C and 1D; Table 1). Here, intermembrane filaments
were observed, as seen upon TSG101 depletion [33]. However,
no obvious build-up of clathrin was seen.
Figure 1. HD-PTP Is Required for EGFR Sorting but Not ILV Formation
(A and B) An early (A) and maturing (B) MVB from control cells after 30 min
anti-EGFR-gold uptake.
(C) Anti-EGFR-gold compartments from HD-PTP-depleted HeLa cells. Anti-
EGFR-gold, white arrowheads; internal membranes, black arrows.
(D) Another region from HD-PTP-depleted HeLa cells, showing anti-EGFR-
gold in tubulovesicular region.
Scale bars represent 200 nm.
(E) Size distribution of ILVs.
(F) IPs, as indicated, were probed by western blot for EGFR.
Table 1. HD-PTP Depletion Disrupts EGFR Trafficking
Compartment Control (%) HD-PTP kd (%)
isolated vesicle/tubule (<80 nm diam.) 4.0 15.1
isolated EE/immature MVB 48.4 5.4
isolated LE/mature MVB 47.6 0.9
cluster; vesicle/tubule – 10.4
cluster; vacuole – 68.2
all compartments > 80 nm diam.:
% a-EGFR lumenal
59.3 10.0
Cells incubated with anti-EGFR-gold were stimulated with EGF for 30 min,
then high-pressure frozen for thin-section EM. Gold was scored over each
compartment. EE, vacuolar, electron-transluscent endosome with ILVs;
LE, electron-dense vacuole with ILVs. Total gold particles in control cells,
798; HD-PTP-depleted cells, 444.
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(Figure 1C; Movie S2), though the total cellular MVB content,
including those in clusters, was reduced (0.10% 6 0.09% SD
relative cell volume density, compared to 0.30% 6 0.11% SD
in controls). 68.2% of anti-EGFR-gold had reached vacuoles,
but 92%of this remained at the limitingmembranes (Figure 1C;
Table 1). By comparison, only 40% of EGFR inMVBs of control
cells was at the limiting membranes. Despite this defect, ILVs
were abundant (Figure 1C, arrows; Figure S1C; Movie S2),
accounting for 18.4% 6 9.6% of MVB volume versus
19.7% 6 6.7% in controls. Some yeast ESCRT mutants allow
ILVs to form, albeit abnormally sized [34]. ILVs in HD-PTP-
depleted cells were similarly sized to those in control cells,
except for a few larger structures (Figure 1E). Clusters
also included tubulovesicular regions (Figure 1D), withinterconnected and sometimes sheet-like elements (Fig-
ure S1D; Movie S3). Though intralumenal membranes were
present (Figure 1D, arrows), all anti-EGFR-gold within
these regions remained at the limiting membranes (Fig-
ure 1D). Less anti-EGFR-gold was internalized in HD-PTP-
depleted cells, implying fewer cell surface EGFR. Indeed,
although total EGFR was reduced only slightly, significant
quantities of EGFR mislocalized to internal membranes in
unstimulated cells, consistent with reported defects in con-
stitutive recycling as well as degradative pathways [32]
(Figures S1E and S1F).
In conclusion, HD-PTP loss affects endosome
morphology and disrupts two aspects of EGFR trafficking.
More EGFR is retained in tubules/vesicles, consistent with
reduced transit to larger endosomes and implying that
HD-PTP may play an as yet undetermined role in membrane
fusion. Principally, however, EGFR sorting to the lumen of
vacuoles is inhibited, despite normal ILVs continuing to
form. By contrast, loss of ESCRT-I abrogates both cargo
sorting and normal ILV generation [33, 35]. Consistent with
HD-PTP engaging EGFR with the MVB pathway, EGFR
coimmunoprecipitated with epitope-tagged or endogenous
HD-PTP (Figure 1F).
HD-PTP Binds STAM2 at Two Sites
HD-PTP binds the ESCRT-III subunit CHMP4B within its Bro1
domain [32, 36] and the ESCRT-I component UBAP1 within its
putative V domain [11] (see Figure 2A). To further investigate
how HDPTP integrates with the ESCRT pathway, we screened
the Bro1-V fragment, which provides theminimal essential unit
supporting the endocytic function of HD-PTP [32], by yeast
two-hybrid (Y2H) against a cDNA library. This identified five
clones containing aa 267–416 of STAM2 (see Figure 2A). Based
on structural studies of the STAM1/Hrs dimer [6], this region
spans the STAM2 ‘‘core’’ domain, which binds Hrs. Directed
Y2H via full-length STAM2 confirmed the interaction, with
full-length HD-PTP binding somewhat more strongly (Figures
S2A and S2B). STAM2 did not bind to the Bro1-V fragment of
Alix, a protein related to HD-PTP that acts during viral budding
and cytokinesis [37] (Figures S2A and S2B). Alix Bro1-V was
folded, since it bound CHMP4B (Figure S2A), as reported
[36, 38].
STAM2 bound the HD-PTP Bro1 domain, but not the V
domain (Figures S2A and S2C). Binding was compromised
by a mutation (L202D/I206D; L/I-D/D) that disrupts HD-PTP
Bro1 binding to CHMP4B [32] (Figures S2A and S2D). This
mutant appears folded, since it binds UBAP1 (Figure S2E).
Bacterially expressed His6-HD-PTP Bro1-V bound in vitro
Figure 2. HD-PTP Binds to STAM2 at Two Sites
(A) Organization of HD-PTP, STAM2, and Hrs.
Single asterisk indicates CHMP4 binding site;
double asterisk indicates UBAP1 binding site.
(B) Translated STAM2 or STAM2(260-416) were
assayed for binding to His6-HD-PTP Bro1-V WT.
(C) Translated STAM2 binding to His6-HD-PTP
Bro1-VWT ormutants (bottom panel showsCoo-
massie stain of the anti-His6 IP).
(D) IPs from HD-PTP-myc or HD-PTP Bro1-
V-myc cells, transfected with HA-STAM2 con-
structs, were analyzed by WB.
(E) IPs from HelaM cells cotransfected with HA-
STAM2 plus WT HD-PTP-myc, or HD-PTP-myc
with SH3 binding mutations (4 3 PRR mut),
were analyzed by WB.
(F) Diagram summarizing how STAM2 binds HD-
PTP and other effectors (aa residues in italics).
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Binding was likewise compromised by the L/I-D/D mutation
but not by a mutation (F678D) that prevents HD-PTP binding
to UBAP1 [11] (Figure 2C). Hence, ESCRT-0 and ESCRT-III
may occupy overlapping sites within the HD-PTP Bro1
domain.
Immunoprecipitations from cells expressing HD-PTP-myc
and HA-STAM2 constructs pointed to additional modes of
binding (Figures 2D and S2F). Specifically, full-length HD-
PTP-myc bound STAM2 much more efficiently than did HD-
PTP Bro1-V (Figure 2D), extending our initial observations by
Y2H (Figure S2B). A mutation (L176A/S177A) that abolishes
STAM2 UIM activity [30] reduced STAM2 binding to HD-PTP
Bro1-V-myc (Figure 2D). Hence, this interaction may be regu-
lated by ubiquitin binding, though we have not explored this
further. In contrast, deletion of the STAM2 SH3 domain
dramatically reduced interaction between STAM2 and full-
length HD-PTP (Figure 2D).
We therefore searched for potential STAM2 SH3-binding
peptides in HD-PTP. Two peptides (KKPPPRP and PLLPRR)
localized to a stretch (K714KPPPRPTAPKPLLPRR730) immedi-
ately distal to the V domain and including a PTAP motif
that binds TSG101 [36]. This also contains the sequence
PPPRPTAPKP, which binds the Mona SH3 domain [39] and
closely resembles the PXXXRXXKP motifs in UBPY [21, 28]
and AMSH [20] that bind STAM SH3. A mutation
(P716A,P717A,P728A,R730A) in HD-PTP-myc reduced HA-
STAM2 binding substantially (Figure 2E). To fine-map the inter-
action, we employed Y2H as a more sensitive assay. Here,
binding between full-length STAM2 and HD-PTP was not
affected by the L/I-D/D (CHMP4Bbinding)mutation or by addi-
tional mutation of P716 but was lost when P717 was mutated
(Figure S2G). Mutants lacking P717 still bound TSG101, and
hence were expressed normally (Figure S2G). As expected,
a P716A,P717A mutant bound STAM2 if the Bro1 domain
was wild-type. In summary, STAM2 binds to HD-PTP via twosites that contribute to other molecular
interactions (Figure 2F).
In cells, STAM2 and Hrs form
ESCRT-0. HD-PTP associated with en-
dogenous ESCRT-0, as evidenced by
its coimmunoprecipitation with Hrs and
STAM2 (Figures 3A–3C) and the precise
colocalization of Hrs and HD-PTP (Fig-
ure 3D; color merge in Figure S3).Binding of HD-PTP to both EGFR and ESCRT-0 occurred in
serum-starved cells but increased slightly within 2.5 min of
EGFR activation. Clearly, however, these interactions declined
after 15–30 min (Figure 3E). Because ESCRT-0 interacts with
EGFR [40, 41], it was possible that association of HD-PTP
with EGFR occurred via ESCRT-0. However, depleting Hrs by
siRNA (which also depletes STAM [42]) did not alter HD-PTP
binding to EGFR (Figure 3F). In summary, HD-PTP associates
with ESCRT-0 and is released after EGFR activation.
HD-PTP Controls Transfer of EGFR from ESCRT-0
to ESCRT-III
HD-PTP interacts with cargo and multiple ESCRTs and is
required to translocate EGFR into ILVs. Hence, HD-PTP may
help to transfer EGFR from ESCRT-0, which sequesters ubiq-
uitinated cargoes, through to ESCRT-III, which drives ILV
formation. If this were the case, we would expect that HD-
PTP depletion would impair the release of ESCRT-0 from
EGFR and prevent EGFR from associating with ESCRT-III.
We first assessed the timing of EGFR association with
ESCRT-0 in control cells. As shown previously [41], we de-
tected a wave of EGFR associating with Hrs 2–5 min after
EGF stimulation, before declining over 15–30 min (Figure 4A).
We also examined endogenous EGFR-Hrs association in
intact cells, using the Duolink proximity ligation assay (PLA)
[43]. Here also, levels of Hrs-EGFR association rose sharply
soon after EGF stimulation, before declining (Figure 4B).
We next examined how depleting HD-PTP affected EGFR-
ESCRT interactions, focusing initially on ESCRT-0. Levels of
both Hrs and STAM2 were reduced in HD-PTP-depleted cells
(Figures 4C and S4A). This could not account for the impair-
ment in EGFR sorting, however, because ESCRT-0 depletion
generates a quite distinct EGFR-sorting defect ([35]; our
unpublished data). In addition, treatment of HD-PTP-depleted
cells for 8 hr with the reversible EGFR inhibitor Iressa partially
restored ESCRT-0 levels (Figure S4B) but did not restore the
Figure 3. HD-PTP Associates with ESCRT-0
(A and B) Lysates from HD-PTP-myc-expressing cells were immunoprecip-
itated with anti-myc (A) and anti-STAM2 (B) and probed by WB.
(C) An HD-PTP immunoprecipitate from cell lysates was probed with
anti-Hrs.
(D) RPE cells were immunostained for endogenous Hrs and HD-PTP. Scale
bar represents 10 mm.
(E) Lysates from cells challenged with EGF as indicated were immunopre-
cipitated and probed by WB. A control IP was from cells stimulated with
EGF for 2.5 min.
(F) Lysates from control or Hrs-depleted cells were immunoprecipitated and
probed by WB.
Current Biology Vol 23 No 6
456EGF transport defect in subsequent experiments (Figure S4C).
Intriguingly, ESCRT-0 turnover is dependent on Cbl ubiquitin
ligase and may be linked to its phosphorylation cycle [44].
Hence, the pronounced loss of ESCRT-0 we observed may
point to an impaired functional cycle caused by loss of HD-
PTP. Indeed, consistent with reduced ESCRT-0 release from
endosomes, virtually all the remaining ESCRT-0 was mem-
brane associated, in contrast to its mainly cytosolic distribu-
tion in control cells (Figure S4D).
Strikingly, despite diminished Hrs, more Hrs was found in
EGFR immunoprecipitates from unstimulated HD-PTP-
depleted cells compared to controls (Figure 4D), consistent
with a failure to release ESCRT-0 fully from cargo. Indeed,
the proximity ligation assay showed that in contrast to the
dynamic association of ESCRT-0 and EGFR seen after stimu-
lating control cells with EGF, this association was stable and
EGF independent upon HD-PTP depletion (Figure 4E). Hence,
HD-PTP helps release EGFR from ESCRT-0. These effects on
ESCRT-0 were not simply due to general disruption of ESCRT
function, because depletion of the ESCRT-I subunit TSG101
did not alter Hrs levels (Figure S4E). Although Hrs-EGFR asso-
ciation increased somewhat in TSG101-depleted cells, this
increase was clearly weaker than the effect of HD-PTP deple-
tion (Figure S4E).
To assess the interaction of EGFR with ESCRT-III, we ex-
pressed myc-tagged CHMP4B. EGFR coimmunoprecipitated
with CHMP4B-myc in extracts from control cells challengedwith EGF for 15 min but not from HD-PTP-depleted cells
(Figure 4F). In conclusion, the changes in EGFR-ESCRT
binding and failure in EGFR sorting observed upon HD-PTP
depletion suggest that HD-PTP may act to release EGFR
from ESCRT-0 and subsequently allow it to engage ESCRT-III.
HD-PTP Combines ESCRT Competition with UBPY
Recruitment to Sort EGFR
The overlapping STAM2 and CHMP4B binding sites within the
Bro1 domain might contribute to the ability of HD-PTP to
switch EGFR from ESCRT-0 to ESCRT-III. We therefore tested
whether STAM2 and CHMP4B do indeed compete for HD-PTP
binding at this site. GST-CHMP4B, but not GST, bound effi-
ciently to His6-HD-PTP Bro1-V and interfered with the binding
of in vitro translated STAM2 (Figure 5A). To examine ESCRT
competition in a cellular context, we used the proximity liga-
tion assay to measure association between stably expressed
HD-PTP-myc and endogenous CHMP4B, using an antibody
that is highly specific for CHMP4B among ESCRT-III subunits
(Figure S5A). This signal was not affected in cells expressing
GFP alone, but was significantly reduced in cells expressing
GFP and cotransfected with HA-STAM2 (Figure S5B;
p < 0.001).
Although these data are consistent with an exchange occur-
ring between ESCRT-0 and ESCRT-III on HD-PTP, additional
mechanism(s) must be in play to release ESCRT-0 from HD-
PTP and EGFR and account for the vectorial transit of cargo
through the ESCRT pathway. We focused on the interaction
of the STAM2 SH3 domain with the proline-rich peptide of
HD-PTP, because STAM2 binds three similar peptides within
UBPY [21, 28]. Hence, locally recruited UBPY might aid the
displacement of STAM2 fromHD-PTP. Intriguingly, the pheno-
types of UBPY and HD-PTP depletion resemble each other in
several respects, including the destabilization of ESCRT-0
[23]. Additionally, S. cerevisiae Bro1p recruits and activates
Doa4p, the yeast ortholog of UBPY [34, 45]. We therefore
asked whether HD-PTP helps recruit UBPY to EGFR. Indeed,
depleting HD-PTP prevented endogenous UBPY from associ-
ating with EGFR (Figure 5B), consistent with increased EGFR
ubiquitination (Figure S5C). The failure to recruit UBPY to
EGFR was not due simply to the reduction in ESCRT-0 levels
caused by HD-PTP depletion, since siRNA of Hrs, which
reduced Hrs levels still further (Figure S5D), did not affect
UBPY-EGFR association (Figure S5E).
In keeping with the importance of HD-PTP for recruiting
UBPY to EGFR, endogenous UBPY coimmunoprecipitated
with HD-PTP-myc from cell lysates (Figure 5C). UBPY
also coimmunoprecipitated with the Bro1-V fragment of HD-
PTP but less efficiently (Figure 5C). Hence, like STAM2,
UBPY may bind HD-PTP at multiple sites. We investigated in
more detail how UBPY bound HD-PTP Bro1-V. We focused
on the N-terminal MIT domain of UBPY, which also binds
CHMP4B, because this is essential for recruiting UBPY to
endosomes and supporting EGFR degradation [19]. More-
over, S. cerevisiae Bro1p recruits Doa4p to the endosome
via an interaction between the N-terminal regions of each
protein [34].
Binding of GST-UBPY MIT to His6-HD-PTP Bro1-V was not
detected (Figures 5D and S5F). However, when GST-CHMP4B
was also provided, efficient recruitment of GST-UBPYMIT, but
not GST, to His6-HD-PTP Bro1-V was observed. In contrast,
binding of CHMP4B to His6-HD-PTP Bro1-V was not influ-
enced by UBPY MIT. Altogether, these data indicate that
CHMP4B binds the MIT domain of UBPY and the HD-PTP
Figure 4. Loss of HD-PTP Affects Transfer of
EGFR from ESCRT-0 to ESCRT-III
(A) IPs of lysates from HeLaM cells, challenged
with EGF, were probed by WB.
(B) Top: PLA analysis of EGFR-Hrs association in
cells pulsed with EGF. Values are means 6 SD
from three experiments. Bottom: Representative
image showing EGFR-Hrs PLA product colocaliz-
ing with Alexa 488-EGF after 5 min uptake
(arrows).
(C) HeLaM cell extracts were analyzed by WB.
(D) EGFR IPs were analyzed by WB.
(E) PLA of EGFR-Hrs association in control
(triangles) or HD-PTP-depleted (squares) cells
after EGF stimulation. Values are means 6 SD
from three experiments.
(F) IPs from cells expressing CHMP4B-myc,
15 min after treatment with EGF, were analyzed
by WB.
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that CHMP4B additionally activates UBPY MIT to bind HD-
PTP Bro1-V directly. To test for additional UBPY binding sites
within HD-PTP, we examined the ability of full-length HD-PTP
L/I-D/D to bind UBPY, because this mutant cannot bind
CHMP4B (Figure S2D). Binding was not affected significantly
(Figure 5E).
These binding reactions provide a scenario in which UBPY
could aid transit of EGFR to ESCRT-III by helping to displace
STAM2 from HD-PTP (Figure S5G). Loss of UBPY function
enhances EGFR ubiquitination, but studies differ in their
conclusions about how this affects EGFR trafficking [19,
23–29]. We therefore examined in detail the consequences of
UBPY depletion (Figure S6A). First, fluorescent EGF and
EGFR degradation was impaired, and ubiquitinated proteins
accumulated on endosomes (Figures S6B and S6C), as
described previously with different siRNA oligonucleotides
[19, 23] and as also seen upon HD-PTP depletion (Figure S6D).
We then tested by EM whether UBPY is important for MVB
sorting of EGFR. UBPY depletion disrupted anti-EGFR-gold
trafficking to mature MVBs and lysosomes (Table S1) and
induced endosomemorphologies reminiscent of, albeit some-
what milder than, those seen with HD-PTP depletion (Figures
6A, 6B, and S6E;Movie S4). Features typifying UBPY depletion
included endosomal clusters, as shown previously [23], but
generally less extensive than those seen after depleting HD-
PTP (Figure 6A, panels i, iii); MVBs with apparently normalmorphologies but reduced lumenal
anti-EGFR-gold (Figure 6A, panels ii,
iii); and swollen endosomes containing
large membrane inclusions as well as
abundant ILVs, with anti-EGFR-gold
located mainly at the limiting membrane
(Figure 6A, panel iv; Figure S6E; Movie
S4). Quantitative analysis showed a
delay in anti-EGFR-gold sorting to the
lumen, with only 39.0% entering the
lumen of compartments after 30 min,
compared to 83.3% in control cells (Fig-
ure 6B; Table S1). However, this defect
was less severe than that caused by
HD-PTP depletion. Most anti-EGFR-
gold eventually reached the lumen of
late endosomes or lysosomes, thoughtransit to lysosomes was relatively inefficient (Table S1). In
keeping with this intermediate phenotype, UBPY depletion
partially reduced the interaction of EGFR with ESCRT-III (Fig-
ure 6C). In summary, we conclude that HD-PTP plays an
obligate role in EGFR transit to ESCRT-III and MVB sorting,
while UBPY functions to facilitate this pathway (Figure 6D).
Discussion
In this study we identify an essential role for HD-PTP in sorting
EGFR to ILVs within the MVB, but not for ILV formation per se.
UBPY also contributes to EGFR sorting. Yeast Doa4 mutants,
or Bro1 mutants unable to bind Doa4p [34], also result in
defective cargo sorting while maintaining ILV formation.
Collectively, these data point to a central role for Bro1 proteins
and endosomal DUBs in allowing ubiquitinated endocytic
cargo to engage productively with the ESCRT pathway.
Although we show that HD-PTP associates with EGFR, we
as yet do not know whether HD-PTP binds EGFR directly,
norwhether it regulates the trafficking of other signaling recep-
tors. Certainly, the presence of normal ILVs in cells lacking HD-
PTP implies the existence of other cargo entry routes into the
MVB (notwithstanding the possibility that ILVs could form
without cargo). The HD-PTP-related protein Alix participates
in multiple ESCRT pathways but is dispensable for efficient
EGFR sorting [24, 32]. However, recent reports identify
substrates for Alix-dependent ILV-sorting pathways [46], in
Figure 5. ESCRT-III and UBPY Displace ESCRT-0 from HD-PTP
(A) Left: TranslatedSTAM2wasassayed forbinding toHis6-HD-PTPBro1-VwithorwithoutGST-CHMP4B.Bottom:Quantitation fromthreeexperiments6SD.
(B) EGFR IPs were probed by WB.
(C and E) Myc IPs from cells expressing HD-PTP-myc constructs (C) or WT or mutated HD-PTP-myc (E) were probed by WB.
(D) His6-HD-PTP Bro1-V was incubated with or without GST-CHMP4B and either GST or GST-UBPY MIT. Samples were Coomassie stained (or blotted for
GST; Figure S5F); arrow shows GST-UBPY MIT. Asterisks show degradation products.
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esis [47].
Our work shows that HD-PTP function is closely linked with
ESCRT-0, with two binding modes identified. That involving
the Bro1 domain appears selective, since we could not detect
binding between STAM2 and Alix Bro1. This matches the func-
tional specificity of each Bro1 protein and extends our
previous observation that the HD-PTP V domain selectively
binds UBAP1, a component of an ESCRT-I complex important
for endosomal sorting of ubiquitinated cargoes but not for
cytokinesis [11, 12]. The overall architectures of the HD-PTP
and Alix Bro1 domains are similar, including the CHMP4B
binding groove [48]. However, the structures differ in several
respects, such as the loop centered on Phe105 that confers
a selective ability of Alix to bind HIV-1 Gag [48]. The specific
binding of STAM2 to HD-PTP suggests that it contacts the
Bro1 domain beyond the CHMP4B binding groove, though
our data also indicate that STAM2 and CHMP4B binding are
incompatible with each other.
As our study highlights, the presence of such overlapping
binding sites provides the potential for HD-PTP to switch
ESCRTs, supporting its action during EGFR sorting. Critically,
however, further mechanisms must ensure that movement of
cargo through the ESCRT pathway is vectorial. We provide
evidence that UBPY forms one component of this regulatory
process. Based on our findings and those in the literature,
UBPY may have a dual function. First, the coordinated recruit-
ment of CHMP4B and UBPY to HD-PTP would bring about
exchange reactions that disrupt both modes of STAM2binding to HD-PTP (Figure 6D). Second, deubiquitination of
cargo by UBPY would favor association of ESCRT-III over
ESCRT-0 with a HD-PTP-cargo complex, given the impor-
tance of multivalent ubiquitin binding in allowing ESCRT-0 to
sequester cargo [3, 8, 49]. Consistent with this model, both
its catalytic activity and the MIT domain are essential for
UBPY function during EGFR trafficking [19, 23]. S. cerevisiae
Bro1p binds ESCRT-I and ESCRT-III [45] and is important for
recruiting Doa4p to cargo [34, 45]. Additionally, however,
Bro1p activates Doa4p catalytic activity [34], and it is possible
that HD-PTP fulfils a similar role to couple ESCRT exchange
more completely with cargo deubiquitination. Although
UBPY-dependent deubiquitination facilitates vectorial transit
of EGFR, it is not obligate for ILV sorting, in keeping with the
ability of artificial cargoes fused to ubiquitin to sort to the
MVB [49].
Our study provides a rational basis for explaining exchange
between early and late ESCRTs. However, furthermechanisms
must direct and regulate this process. First, ESCRT-I is also
essential for EGFR sorting [33]. While HD-PTP interacts with
ESCRT-I via two PTAP motifs within its PRR that bind
TSG101 [36] and via binding to UBAP1 [11], much more work
is needed to ascertain precisely howESCRT-I function is linked
to that of HD-PTP. Additional factors that may provide direc-
tionality to an ESCRT exchange reaction include the polymer-
ization of ESCRT-III and subsequent entrapment of EGFR
within the developing ILV that would render it incapable of re-
engaging ESCRT-0 and the influence of tyrosine phosphoryla-
tion and PTPases on the activity status of ESCRTs [50]. In this
Figure 6. UBPY Facilitates EGFR Sorting to the MVB
(A) Representative endocytic compartments from UBPY-depleted cells after 30 anti-EGFR-gold uptake. Scale bars represent 200 nm.
(B) Percentage of anti-EGFR-gold in lumen of all compartments; see also Table S1. Values are means 6 SD from the indicated number of cells (brackets).
*p < 0.001.
(C) Anti-myc IPs from cells expressing CHMP4B-myc (15 min treatment with EGF) were analyzed by WB.
(D) A model for HD-PTP and UBPY function. HD-PTP first binds EGFR and ESCRT-0. Recruitment of CHMP4B and UBPY to HD-PTP displaces STAM2/
ESCRT-0 from HD-PTP. In conjunction, STAM2 binding facilitates UBPY-dependent deubiquitination of EGFR, supporting release of ESCRT-0 from
EGFR in favor of ESCRT-III.
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459context, the possible PTPase function of HD-PTP may be
significant. A further point of investigation is at what point, if
at all, HD-PTP is released from ILV-bound EGFR.
Experimental Procedures
Reagents
A list of cell lines, antibodies, molecular biology and transfection reagents
is in Supplemental Experimental Procedures.
Yeast Two Hybrid
Y2H screening was performed by Hybrigenics, S.A. (Paris, France) (http://
www.hybrigenics-services.com). Directed two-hybrid used MatchmakerGold (Clontech). Full details are in Supplemental Experimental
Procedures.
Immunoprecipitations
For native IPs, cells were lysed in IP buffer (25 mM Tris-HCl [pH 7.5], 40 mM
NaCl, 0.5% IGEPAL) containing PIC-III (Sigma). Denaturing IPs used RIPA
buffer (IP buffer also containing 0.1% SDS, 1% sodium deoxycholate,
50 mM NaF, 2 mM Na3VO4, 10 mM NEM). Lysates were clarified at
14,000 rpm for 15min at 4C and incubatedwith antibodies at 4Covernight,
then 3–4 hr with protein A sepharose (Zymed), preblocked with 50 mg/ml
BSA. Beads were washed four times in IP buffer, then analyzed by western
blot (WB). Control IPs used nonimmune sera or IgGs. To analyze total
extracts only, cells were lysed in IP buffer containing 0.1% SDS and clari-
fied. Western blots used HRP-secondary antibodies and ECL, or Li-Cor
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460secondary antibodies. Panels for all figures have been cut from the same
exposures unless stipulated in the figure legend.
Pull-Down Experiments
Translations of PCR products using [35S]methionine and nuclease-treated
reticulocyte lysates (Promega) were terminated with 1 mM puromycin.
Products were incubated with 5 mg His6-HD-PTP Bro1-V in 50 mM HEPES
(pH 7.4), 100 mM NaCl, 0.1% Triton X-100 (Anatrace), 1 mM methionine,
and PIC-III for 4–6 hr at 4C. Incubations were clarified with protein
A-sepharose. Anti-His6 (4 ml) was added and IPs continued as above.
Samples were analyzed by phosphorimager. A similar protocol was used
to examine binding of GST-fusion proteins.
Subcellular Fractionation
Cells (2 3 15 cm dishes per sample) were trypsinized, collected in 50 ml
complete medium, and pelleted at 1,500 rpm for 5 min at 4C. Cells were
washed twice with buffer A (3 mM Mg acetate, 5 mM EGTA, 10 mM HEPES
[pH 7.4], 250 mM sucrose), resuspended in 2 ml buffer A containing PIC-III
and 1 mM DTT, and homogenized with a ball-bearing homogenizer
(Isobiotec, Germany). A postnuclear supernatant was prepared by centri-
fuging twice at 3,000 rpm for 10 min, and 1.5 ml was loaded on a 25%
sucrose cushion in buffer A (800 ml) and centrifuged at 200,000 3 g for
30 min at 4C. The cytosol was removed and the pellet washed with buffer
A and solubilized directly into SDS-PAGE buffer.
Immunofluorescence and Imaging
Pulse-chase experiments with Alexa 488-EGF were performed as
described, with EGF pulsed for 3 min at 37C and chased in unlabelled
medium [11]. Details of IF labeling conditions and image acquisition are in
Supplemental Experimental Procedures. The Duolink PLA system (OLink
Bioscience) was used according to the manufacturer’s instructions.
Electron Microscopy
For EM pulse-chase analysis, 18 nm colloidal gold was conjugated to
affinity-purified anti-EGFR, MAb 108. Cells were subjected to high-pressure
freezing or conventional fixation as indicated. Reagent preparation, sample
processing, and quantitation details are in Supplemental Experimental
Procedures.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, six figures, one table, and four movies and can be found with this
article online at http://dx.doi.org/10.1016/j.cub.2013.02.033.
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